日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MLN0905 effectively kills gemcitabine-resistant pancreatic cancer cells by targeting PLK1.

MLN0905 通过靶向 PLK1 有效杀死吉西他滨耐药的胰腺癌细胞

Lin Min, Pan YongSha, Han Shanshan, Zhu Lifei, Ye Peng, Ye Ming, Fang Zejun

HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression

HDAC抑制剂可增强巨噬细胞的抗肿瘤活性,并增强抗PD-L1介导的肿瘤抑制作用。

Li, Xiaolei; Su, Xiao; Liu, Rui; Pan, Yongsha; Fang, Jiankai; Cao, Lijuan; Feng, Chao; Shang, Qianwen; Chen, Yongjing; Shao, Changshun; Shi, Yufang

Harnessing tumor-associated macrophages as aids for cancer immunotherapy

利用肿瘤相关巨噬细胞辅助癌症免疫治疗

Li, Xiaolei; Liu, Rui; Su, Xiao; Pan, Yongsha; Han, Xiaofeng; Shao, Changshun; Shi, Yufang